Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹348 Cr
Revenue (TTM)
₹107 Cr
Net Profit (TTM)
₹8 Cr
ROE
12.7 %
ROCE
13.6 %
P/E Ratio
43.3
P/B Ratio
3
Industry P/E
32.35
EV/EBITDA
26
Div. Yield
0 %
Debt to Equity
0.5
Book Value
₹60.5
EPS
₹7.7
Face value
10
Shares outstanding
13,038,400
CFO
₹22.78 Cr
EBITDA
₹51.99 Cr
Net Profit
₹35.59 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Hemant Surgical
| -8.2 | -11.5 | -7.5 | 187.3 | -- | -- | -- |
|
BSE Healthcare
| -4.0 | -3.8 | -4.0 | 3.0 | 24.6 | 15.5 | 10.6 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Hemant Surgical
| 130.9 | -25.2 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Hemant Surgical
|
267.2 | 348.4 | 106.6 | 8.0 | -- | 12.7 | 43.3 | 3.0 |
| 695.0 | 1,257.0 | 77.0 | 16.4 | -- | 43.4 | 79.6 | 29.5 | |
| 1,596.8 | 26,315.7 | 6,112.8 | 847.2 | 17.2 | 9.2 | 31.1 | 2.7 | |
| 177.2 | 973.9 | 264.6 | 19.3 | 8.9 | 6.2 | 42 | 4.2 | |
| 820.6 | 9,847.5 | 6,537.7 | 207.0 | 4.6 | 11.5 | 47.6 | 5.2 | |
| 1,240.5 | 12,526.5 | 1,781.6 | 341.3 | 19.8 | 12.4 | 36 | 4.2 | |
| 376.1 | 451.4 | 71.3 | 19.8 | 31.4 | 17.9 | 22.8 | 3.8 | |
| 182.3 | 969.2 | 414.3 | 20.3 | 8.0 | 3.4 | 47.6 | 1.5 | |
| 463.9 | 521.4 | 18.6 | 25.3 | -9.9 | -10.2 | -- | 0.6 |
No Review & Analysis are available.
Manufacture of laboratory apparatus (laboratory ultrasonic cleaning machinery, laboratory sterilizers, laboratory type distilling apparatus, laboratory centrifuges etc.)
Incorporated
1989
Chairman
Hanskumar Shamji Shah
Managing Director
Hanskumar Shamji Shah
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Hemant Surgical Industries Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Hemant Surgical Industries Ltd is ₹267.20 (BSE) as of 19-Mar-2026 IST. Hemant Surgical Industries Ltd has given a return of 187.31% in the last 1 years.
The P/E ratio of Hemant Surgical Industries Ltd is 43.33 times as on 19-Mar-2026, a 34 premium to its peers’ median range of 32.35 times.
The P/B ratio of Hemant Surgical Industries Ltd is 3.05 times as on 19-Mar-2026, a 9 premium to its peers’ median range of 2.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
12.94
|
1.65
|
|
2024
|
14.18
|
2.53
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Hemant Surgical Industries Ltd are Rs 367.10 and Rs 89.99 as of 19-Mar-2026.
Hemant Surgical Industries Ltd has a market capitalisation of ₹ 348 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Hemant Surgical Industries Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-4.80
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.